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Fali~m# with diabetes haw gr~aur morbidity #nd m01Itdily 
fmm cwdkwa~~ular disease than du nondpbetic @IItS 
(1). In particular, dlPbetic psticnts hsve been #hewn to 
have a pctor outcome after awte q yoC#rdi#l infiu~t.@ 
iwludiry I hi&r incidence uf conpsstive hcsll f&bux 
kwiou# studies compuis diabmii and mndblic po- 
tiat#wilbacukmyowdMinfarCtionbnv4foundthathm4 
With diNbCtC# Mui lu b# ddCr e-61, Lo bavC I hi&r 
iMe of prior myomrdii i&rfSm (23.6) aml lo MC 
-what wam4 loll v~m#iCulu wn (3). Ulh~qh 
di4b4t4rharkenthowpfoprCdiftaniucrraedmLd 
morMity inkpcndatly dboth baline C&&A cham~tec 
rtic#(2-4)andmdimuclideIcRveotricldar~eClinnRaCtioa 
inthelweaUeofinfarCtioniono.nolludicahmnpor(Cd 
rarultNOfCOM~YOrrCgklMll&MnbieUllU 
lbnCli~illpsllelUNWilhdblbclsN#f#iaclltc~ 
blt&rioa. ~tUIltiM# ill U~#t&l fUKtiM 8) Oc Bbrimlvtic 
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Mamil 15. lKmQlb5 DIABETES AND MyocARD,AL INFARCMN 
addreasal. Moreover, the otltwtne of acllfc myocardlal 
infarction after tkrnmbdytic therapy in patients with diabe- 
tes has not been well studmd. 
The purposa of this study therefore was to assess oot- 
come in diabmic patients &en tbrombolytic therapy and to 
detmmtne wbetbar d&renccs in an&graphic characteris 
tics-vessel patcrazy. left ventricular function or coronary 
anatomy+nny account for the worst ootconu observed in 
diabetic patients. 
MdMldS 
Rudy p&at& From December 1985 to April 1969. I 47 I 
patiauts were enrolled in the Urokinasc trial (II! or the 
Tbro&olyais aod Angioptasty in blyacardial lnt&ctian 
(TAbiN I, 2, 3 or 5 triats *ho underwxat acate cardiac 
catbet&zation. The TAMI trials were designed to cvrhtate 
varioos rqmfusiin strategies in acute myocnrdial infarction. 
Ali of these studies shared simiku inclusion and edusiou 
crltaria, wbiih have been detaiid pravloosly (11-15). En- 
hnnce criteria it~ludcd clinical evidence of acute myocardial 
imfar&n witbbt 4 to 6 h of symptom ooset and ST segment 
elevation >I mm in at least two cont&uc4rs Icads. Patients 
were eucbtded tkom the trials if they euparienced chest pain 
dutation of C2O min, were >75 years of age. presented in 
cardioacnic shock. had orior comaarv artery bvnass sur- 
gery,~~QrvavcmyocPrdiPlinfarctioninIhe~tribution 
oftba ittfbtct-ralatad artery or contrabtdiutions to tbrombo- 
lytic therapy incbldit&t prior stt&. ecent suEcry or 
trauma, +caxy bypertenaion. active bleedin 0T pm- 
b-d cardroplbnoMly rcsuacitatlon. Although diabetes 
it&was not an exchmion criterion. severe compliitii of 
diatnttcr. such as his&try of datinite hemorrhagic diitic 
retinnnathY. may have resulted in aaclusiun. denendina on 
tba~t&&c&baattendittgphysiciau. . _ 
over the aext !M mitt) or a combtna6on of r&PA (I mg&g 
over 60 mini and omkinasc (I.5 million U ovar 60 mitt). In 
the Urokinase study (IS), IO2 p&ents received high dose 
urokhtase (3 atillion U over a 45. to &ntn period). 
Cmdtaccathtterialird~~. lneach 
study, patients under~nt two madiac catbct&arion pro- 
cedures. the first at appmximatcly 90 mitt after initiation of 
thrcmbolytic therapy and the second 7 to IO days later. The 
Oow in the infarct-related artery was rated according to tbc 
Tbrombolysis in Myocardial lnfarctlon fTIMI) clan 
(161. All those with an initially occluded artery fliIMI gtadc 
0 or I) and suitable anatomy un&weut attempted auonaty 
angioplasty at the 9Omin catbetaiaatioo. For patients with 
TIM1 grade 2 or 3 tbw and suitable anatomy. emergency 
angioplast~ ~11s pdiwmcd according to randemtaed asa& 
ment (121 or if per&cm iscbcmia wss pment (It-IS). A 
measure of “diEit& disease was defined as the total num- 
ber of comnary artery qmcuts @ft main = 1, left ant&r 
cIescendirr3 = 3, left citcumllex = 2. r&bt rummary q 2) with 
at least one a25Sb stenosis. 
Fdbw-up CIC. Samlard tart after leaving the catltatcr- 
ization laboratory included inttnvenous beparin for I to 7 
days, prophytactic iatnw- lidocainc in most patients. 
oral diltiazem in most patients and aspirin (325 m&lay). Lam 
revascularization procedures were prformed at the diserc- 
lion d Ike individual catdioloaist. 
w Ibarpg. As descrii &awkare (I I-15). 
each of tkaae atudias imwlvad tke use of inhuvcnuus -- 
binant tissue @amninugau activatur (rt-PA). urokinasc or a 
oombiuatiou of t&PA and tuokbtasc. In the TAM3 1 tial 
(12). the &at I78 ptients received 60 atg ofrt-PA during tkc 
l~h,l0~duriyrl#2ndand3rdhaPdlO~foreaeh 
d the last 5 h. In the remminin~ 208 pdmts, the dose was 
I m&body w&gist for tha 1st h (maxinrsl dose 90 n@. with 
tlte remaining dose divided uver a S-h intitaion for a total 
dare of LSO tag. In aU patients, 10% of the M-h doac was 
arimiuistemd as au intrav~~~s bolus ittWon over 6 min. In 
the TAMI 2 !risl (1% I46 patients received combination 
therapy wttb rbPA and -. The lksk 34 patients 
received 25 mg of ti-PA in addition b urokinase (0.5 to I 
millii Lll. The remaining II2 ptients m&ad I III&l of 
rt-PA in addii to urokinase at varying doses (0.5 to 2 
mlllinn v). la tke TAG 3 trial (14). I76 patients raceivad 
I.5 ntgl~ of a-PA. In tire TAMI 5 triai (1% patients were 
ramI&aad to receive either rt-PA (a0 mg over tke 1st h, 
thcn20~rwmtn~2hforarould100ms).urokin 
(1.5-millim U bolus infualnn pld an mldlttnnat 1.5 mtllion U 
LM&iau af dt&tw. A batient was da&ted as bavina 
diabetes if a physician had &gnoscd diabctoa before w 2 
the tbne of the cununt myocardtal infarction To datamdna 
mathnd of traatmant kafnra the hospital dmission. a ret~ 
spectivecbartreviawwaspmformctlt0add~t0tbC 
prospective TAMI data base and eack patient with diabetes 
was classified as being tteatotl with iusuiiu. au oral hypagly- 
cemic agent. both or uaitbar. Tlta presence of diabetic 
retinopathy was assassad by a rctmspective chart review, 
and systematic datatted ophthalmolngic -natinns were 
nut performed urramrdad. 
kbtafaucarw.~~portforaulW~Completcdby 
nurse study coordinatnrs at each site, raviawad by inverti- 
gaton at aach site amt submitted to tka TAMI Cuordinatk@ 
Center at tke Lluke Cardiuvascutar Disease Databank All 
case report forats were verified a&d tb medical taaunis 
by independent study monttors. Additinnal infmmation 
about diabetes ttuatment, contml and mmplications was 
collected for alI patients with diakntas. 
Data anatysls. To describe the chatncteriatics of tht 
patients, mean vaktcs t SD are used b all continuous 
variables known tn ba mutually distributed. Median and 
quartile rang (25th to 75th percen&) are used for all ntker 
continuous variables. Discrete data ara prrsantad as n pr- 
cent. 
Those hypotheses deemodciinicaity imtmrMt were pre- 
specified and tested. A WlIwxon siped-rank tust was used 
to evaluate tkc differences ln laft ventricular ejectinn frap 
tion, regionat wall motion and number OF segments with 
x25% stenosis per patient between patients uitb Versus 
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thoere without disbetes. The diIference in the percent of 
patients with multivessel disease for the two groups wB( 
tested by L chi-square wt. Logistic rcgressiou tcchnisuca 
were used IO determine the uaivariable assuciatlun ufdiabe- 
tes with in-hospital clinical events, specifically mortality and 
pulmonary edema. F’reviour work at this institutioa, usiug a 
set of patients that included theee ia this report, has pre- 
duced a m&l ufbhospital mortality based on results from 
clinical and cardiac catberization varlabks. L&itic re 
gresriun techniques were also used ta evaluate tbc additiw 
and dEerentia1 dfece of diabetes after sdjuatment for these 
other ckmcteristica. The difference iu Img-tem~ mortality 
betweeu these with diabetes versus 110 dioktca was illw 
bated by using Kaplan-Meier curves (pie. 1). Cux propur- 
Uonal haznrda regraarien analysis was ured to test the 
impxtancc of this dikrcnce. 
kswn.?l 
Bnsdlae ptlcnl chmekk0le. The diabetic group con. 
sisted d 148 pstients. that is, 14% of the total study cohort. 
Patients with diabetes wn slightly older and more wm- 
otonly fern& then were these without diebetes (Table I). 
There was a grentet prevalence of hyperte&en Amos 
T&h I. Blacliee Clinical Chamci&tics of l.07l Mmts 
diabetic @ients and a oreater providence of cigmette smuk- 
iw among nondiabetic patieutn. 
Twxnty-eighr percent of patients with diabetes were 
treati with insulin befme f&i&n. 42% with oxl hype 
glycemic *nts end 30% with diet ar no therepy fkble 2). 
Median “randum” admirsiw glucuse level 0IBI 276 n@ 
IO0 ml (a = 143). Ten (7%) of the diitic &ents we= 
noted IO have ditic retinupsthy; however. because sys- 
tematic upbthUo!ugic exankmtimts wwe nut perbmed. 
this is pt&bly en underestimate of the true itcklencE uf 
diilic retinopathy In this gmup. No patient had en&dpge 
tenal dinease. 
&de& e&rMzatbu. llte data tfom the czudirc 
catheterization procedure performed at rppraximately 
90 min aftet tltrombdyk therapy are abowu in Teble 3. 
Median glubl ejection fractioa was 8li&tlY bwer ill tk 
Tcbh3. cwdi~cuhe4cYludonl2am 
DkMw N~DMIws 
bl=l49l b-9231 PVb 
48.6 * 123 61.3 t 11.9 
-2.7 f 1.0 -2.J f I.1 aI5 
-9.13 * I.9 93 * 1.7 a92 
34 54 
II 79 
92 93 

BIN4 7. Cliiical EvenIs in Palknk With I?&bctes in Ibe TAM 
swnl 
cudii tMleteaizaliml SLiateEy 
?z-$ FT = p Vdue 
-- 
Datb 3 4 
smke 0 I 
ndmhli0l I I 
Harllriwe 8 
Rafuncnt irchomia II 2fl 
the deferred catheterization stmtqy (63% in the acute 
catbcterizatioll group wcrc fret b any ofthcsc adverse 
clinical event! wmpared with 52% in the late cathacriation 
pup, p = 0.29). 
Diabetes a8 m unadjluted varloble was asaocioted with 
irrhospitd @ = Mt2) and total Ion&term (p = 0.003) 
mortality (Pip. I). However, after ajjustment for other 
variablea known to at&et nuntality (age. e&at ofeamnnry 
mlety disease, left venhietdar function, vessel patency, 
myocardid infaMion Ination and systolic blood pmssutz), 
WT wire unable to show that dinbetes had an independent 
inilueacs on moxtdlty @ = 0.30). 
lnI?t!assIon 
RdedtiEvdiydcomawywtwydhew.Thetuqiw 
llndiag of this study is that the higber matality mtd mrmplc 
cation rates of patic with diabetes appear to be primarily 
a function af the patisnts’ older age and more acvcrc 
ccmnary artery disease. A hiiher incidence of @mmmry 
edema despite similar overall left vantrieular systdlc Bllo 
don is consistent with prior findIng and 8~ diddle 
dy-sfunetion io pPtiea~s with din&a. The Wig d worse 
nonintit 7.01~ &mal left veniricuk~ hmction in diic 
Patients suggests that the more extensive coronary artery 
disease in nmkfaret vessr~s results in leas eifective can- 
pnsatlcm. 
Althougb many stud& have demonatmted a wae oat- 
come in paGents with diabetes and myocmdial Mrctlon, 
ncae has syatematicdly examined i~-rdated attery pa- 
talcy, Mmoaly anatony and M ventricular runctien. A8 
measured by tbz number of diseased vessels, pntieota with 
diabetes had rign&ntly more severe disease (p < O.OMH). 
~earepOltlharcoronary~seisn~morcd~in 
potMa with diabetes (It))), we found that by one nmwc 
04 number of qpnents with at least one stenoaia b23%), 
patients titb diabetes bad mot? diUW coronary artery 
diaeaae than did thcae wltbout diabetes. 
Diabetes brs beeo associated with a cardioarypparb 
findioCUlatmayhPvemanycauPea(20).Tbe~dm~ 
thm~ twice the incidence of pubnonmy e&ma, despite .sim- 
ilar systolic function as meas by global ejEction e, 
is consistent with the flings and suggestion of Stone et al. 
(3) that diastolic dysfu&on may contribute to the h@her 
clinical ae of heral feilure in diabetic petieot.5 with acute 
olyaprdial infarction. Noninfarct zone function was signif- 
icantly - in tbo~ with diabetes. sqpst& the inability 
of the nonzaxted myocardium to colnpensa as e&z- 
tivety in the gtntp with di&tes, a 6t&g that may be 
explained by the mae severely diseaed noninfarct-related 
nrteriea. 
Baleof- SimilorearlvIBtencvmdreocdu- 
Lmmbolytie therapy lue ml rem for the worse 
outooroo in IhDlc with diabetes. Lk pitc similar ratea of 
reocdusion. petienta with diabetes had nvice the rate of 
clinkally reeogtid reinketioa: this Ming is smnewhn~ 
sumrisiat in lkht of evidence that silent iachemir or ib 
Althoagh o&us have denm&&daworseoatcmaeia 
patkuswithdiisaftereammny~bypassawgmy 
(21) and a!l&7pMy (221, this #fSt was mll nspoa!iible Rx 
thewarseoatcomcin&beticplirmzinfhiaat&kause 
thcmmdityratc*rbypaassurgaya@oplasfywss 
SiUlkWhE4lK@&Uillgth0SCUithEllldWitbXlldillkkS. 
SuciladiaaEncomidltkndssed.llowever.witbthesmdl 
tatd mat&r d inte~klioonr in fhis sludy..Aa 3mJysk aP 
tbeTIMlIltrialhrkmwedtoargacFarr-tivx 
atmtcgy in patienls with diabetes. “,I&: MT 
treatal wilh n-PA were ro&&ed 
Btratqy (mutble cm&c calhekrizallaa &Kl an&pbsty of 
the iaWl-&ted artery when suitable) or a Walive 
&rate# of Ivatchelll wailill& Tile SUbKt of paliem~ with 
diabetesaadwithWlprlormyoWdiiiblkliiwhowbo 
assimxd to tlx Invasive stmteav were louad to have a worse 
outcome than thox as&aed% &e Mnscrvmive stmtagy 
(23). The author polnkd out the prellmiaary nature of the.te 
lndinp and the perils of &group analysis. la eonmat to 
Ihc TM II fimdh4gs, tk curmm aludy &~IOIW&M a 
similar outcome after a *y of routine early versus dc- 
layed catbeterizatlon in patients wirh diabetea, aupportim a 
similar appmoob toward early intervention in Patienta with 
or without debates. 
R&ddbtr~Noincrroreinsaicusbleed& 
complicrtionr WediN mquiring tramfusion lull associated 
withcomMly~rybypssaurgerybrsxmkewasobserved 
in psticnta with diabetes. AHhaugh them have kea mm 
repor& ofreliaal hw in @ients with diabetic I&- 
nopethy 0. there wat no documeaation of ocular hcmor- 
rhaee in this nroop of diabetic uotionfs despite well dca- 
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am consirtent oith prior reports i2526) that women with 
diabetes have a particularly paar outcome, with an io- 
hospital mort&y rate ofZl% in that group. explained bt part 
by the dder age of women with diabetes at the time of 
myocardii ittfktctioa. Because the insulin-treated patients 
tended io be yottngcr. the motlalily rate might have been 
expected to be lower in this pop. However. rypc of 
trzatmeat (insulin, oral hypc&cemic agents or neither) was 
ttot tbuud to be -i&d with ditferences in the incidence 
of pulmonary edema or death. 
conrluaiaag These 6ndings sopport the coocep! that 
c&eats with diabetes are at esuecial!, hiah risk. Thtvmbo- 
lpic ti~rapy is equally e&ctti~in achievi&early patency in 
those with diabetes. and inlervention with coronary artery 
bypa ywgery and cormmy angloplasty is not associated 
N&I a higher incidence ofin-hmpiral complkAnts. Patients 
&h diabetes, themhue, shoohi be considered at hi risk 
for a poor outcome and should be treated in a similar f shion 
as other hii risk grcupa. with early thmmbolytic therapy 
ard p&taps early revascttlarizatiott in those with appmpli- 
atetc. 
